[The second phase clinical observation of anti-radiation effect by superoxide dismutase]
- PMID: 10681768
[The second phase clinical observation of anti-radiation effect by superoxide dismutase]
Abstract
Multiple center randomized controlled double blind clinical trait was conducted to evaluate the anti-radiotherapy effect by SOD (produced by Hunan Biochemical Work) in 159 patients. Injection of 4000U SOD immediately after receiving radiotherapy significantly reduced the occurrence rate of skin, oral mucosal, pelvic visceral and systematic adverse reaction, only the reduction of leukopenia did not reach the statistical significant level. No adverse effect of SOD injection was observed. The results suggest that SOD is a safe and effective agent to attenuate the radiotherapy reactions.
Similar articles
-
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):643-50. doi: 10.1016/j.ijrobp.2006.09.043. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293228 Clinical Trial.
-
Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.Australas Radiol. 2006 Oct;50(5):468-74. doi: 10.1111/j.1440-1673.2006.01628.x. Australas Radiol. 2006. PMID: 16981945 Clinical Trial.
-
Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.Semin Oncol. 2002 Dec;29(6 Suppl 19):80-3. doi: 10.1053/sonc.2002.37350b. Semin Oncol. 2002. PMID: 12577250 Clinical Trial.
-
Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.Semin Oncol. 2002 Dec;29(6 Suppl 19):61-2. doi: 10.1053/sonc.2002.37349. Semin Oncol. 2002. PMID: 12577247 Review.
-
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.Curr Opin Oncol. 2006 May;18(3):266-70. doi: 10.1097/01.cco.0000219256.37843.83. Curr Opin Oncol. 2006. PMID: 16552239 Review.
Cited by
-
Interventions for preventing oral mucositis for patients with cancer receiving treatment.Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD000978. doi: 10.1002/14651858.CD000978.pub5. Cochrane Database Syst Rev. 2011. PMID: 21491378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical